# The Medicines for Human Use (Clinical Trials) Regulations 2004, Regulation 41: Application and effect of manufacturing authorisation

Extent: E+W+S+N.I.

A manufacturing authorisation shall apply only in relation to—
(a) the descriptions of investigational medicinal products;
(b) the manufacturing, assembling or importation operations; ...
(bb) in the case of an authorisation relating to the inactivation of viral or non-conventional agents, the manufacturing process; and
(c) except in the case of an MM investigational medicinal product or a POC investigational medicinal product, the premises,
specified in the application made pursuant to regulation 38 and in respect of which the authorisation is granted.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/regulation/41 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/regulation-41
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.